Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
The Lancet. Gastroenterology & Hepatology|February 25, 2021
The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trialDina Kao, Karen Wong, Rose Franz, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 12, 2015
Usefulness of previous methicillin-resistant Staphylococcus aureus screening results in guiding empirical therapy for S aureus bacteremiaAnthony D Bai, Lisa Burry, Adrienne Showler, et al.
Antimicrobial Agents and Chemotherapy|September 9, 2020
Novel Antibiotics May Be Noninferior but Are They Becoming Less Effective?: a Systematic ReviewAnthony D Bai, Adam S Komorowski, Carson K L Lo, et al.
BMC Medical Research Methodology|April 20, 2021
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic reviewAnthony D Bai, Adam S Komorowski, Carson K L Lo, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2015
Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort studyAnthony D Bai, Adrienne Showler, Lisa Burry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 3, 2017
Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort studyG Sasson, A D Bai, A Showler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 22, 2015
Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort StudyAnthony D Bai, Adrienne Showler, Lisa Burry, et al.
Pageof 16